Tenax Therapeutics
TENX
14 hedge funds and large institutions have $185K invested in Tenax Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
55% more capital invested
Capital invested by funds: $119K → $185K (+$65.6K)
17% more funds holding
Funds holding: 12 → 14 (+2)
0.01% more ownership
Funds ownership: 0.02% → 0.03% (+0.01%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$37.7K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$24.5K |
| 3 |
VF
Virtu Financial
New York
|
+$11.7K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.76K |
| 5 |
Lido Advisors
Los Angeles,
California
|
+$3.17K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$4.97K |
| 2 |
HF
HRT Financial
New York
|
-$3K |
| 3 |
APP
Avantax Planning Partners
Dubuque,
Iowa
|
-$1.6K |
| 4 |
Morgan Stanley
New York
|
-$25 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Corient Private Wealth
Miami,
Florida
| $56.4K | – | – | – |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $35.1K | +$37.7K | +1,487 | New |
|
|
TSS
3
Two Sigma Securities
New York
| $29K | +$24.5K | +966 | +391% |
|
4
State Street
Boston,
Massachusetts
| $28K | – | – | – |
|
|
VF
5
Virtu Financial
New York
| $11K | +$11.7K | +460 | New |
|
6
BlackRock
New York
| $7.15K | – | – | – |
|
7
LPL Financial
San Diego,
California
| $5.98K | – | – | – |
|
|
8
Citadel Advisors
Miami,
Florida
| $4.43K | +$4.76K | +188 | New |
|
|
APP
9
Avantax Planning Partners
Dubuque,
Iowa
| $2.99K | -$1.6K | -63 | -34% |
|
|
10
Lido Advisors
Los Angeles,
California
| $2.99K | +$3.17K | +125 | New |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $1.39K | – | – | – |
|
|
12
Morgan Stanley
New York
| $202 | -$25 | -1 | -11% |
|
13
Wells Fargo
San Francisco,
California
| $48 | – | – | – |
|
|
AF
14
Allworth Financial
Folsom,
California
| $1 | – | – | – |
|
|
TAM
15
Tucker Asset Management
Littleton,
Colorado
| $1 | – | – | – |
|
|
16
Millennium Management
New York
| – | -$4.97K | -207 | Closed |
|
|
HF
17
HRT Financial
New York
| – | -$3K | -145 | Closed |
|
TENX Hedge Fund Activity: Q3 2023 in Review
14 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q3 2023, worth a combined $185K — up 55% from $119K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TENX positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $37.7K. The largest seller was Millennium Management, exiting entirely with an estimated $4.97K sold.
- 14 institutional investors held Tenax Therapeutics (TENX) as of Q3 2023, up from 12 in Q2 2023.
- Funds reported $185K of Tenax Therapeutics stock for Q3 2023, up 55% quarter-over-quarter.
- 4 funds opened new Tenax Therapeutics positions in Q3 2023 and 2 closed out, a net change of +2 holders.
- The largest Tenax Therapeutics buyer in Q3 2023 was Geode Capital Management, an estimated $37.7K added.
- The largest Tenax Therapeutics seller in Q3 2023 was Millennium Management, an estimated $4.97K sold.
Based on aggregated 13F filings for Q3 2023.